Former Editorial Board

Gopal H. Badlani, MD

Department of Urology, Wake Forest University Baptist Medical Center, Winston Salem, NC, USA

Gerald Brock, MD, FRCSC

Division of Urology, Department of Surgery, The University of Western Ontario, London, ON, Canada

Arthur L. Burnett, MD, MBA, FACS

The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD, USA

Peter R. Carroll, MD, MPH

Department of Urology, University of California, San Francisco, CA, USA

Toby Chai, MD

Department of Urology, Yale University School of Medicine, New Haven, CT, USA

Leland W.K. Chung, PhD

Department of Medicine and Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Sakti Das, MD, FACS, FRCS

Department of Urology, University of California at Davis School of Medicine, Davis, CA, USA

Daniel M. Geynisman, MD

Department of Hematology/Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA

Marc Goldstein, MD, DSc (hon), FACS

Center for Male Reproductive Medicine and Microsurgery, Department of Urology and Institute of Reproductive Medicine, Weill Cornell Medical College, New York, NY, USA

William E. Grizzle, MD, PhD

Department of Pathology and Surgery, University of Alabama at Birmingham, Birmingham, AL, USA

Sang Won Han, MD, PhD

Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea

Chou-Long Huang, MD, PhD

UT Southwestern Medical Center, Dallas, TX, USA

Kamyar Kalantar-Zadeh, MD, MPH, PhD

Division of Nephrology and Hypertension, School of Medicine, University of California, Irvine, Orange, CA, USA

Sae Woong Kim, MD, PhD

Department of Urology, Seoul St. Mary’s Hospital, The Catholic University of Korea, College of Medicine, Seoul, Korea

Barry A. Kogan, MD

Division of Urology, Department of Surgery, Albany Medical College, Albany, NY, USA

Herbert Lepor

Department of Urology, New York University School of Medicine, New York, NY, USA

Ching-Shwun Lin, PhD

Department of Urology and Molecular Urology Laboratory, University of California, San Francisco, CA, USA

Jack W. McAninch, MD, FACS, FRCS (Hon)

Department of Urology, University of California, San Francisco, CA, USA

Kevin T. McVary, MD, FACS

Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA

Mikio Namiki, MD, PhD

Department of Integrative Cancer Therapy, Andrology Unit, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan

Akihiko Okuyama, MD, PhD

Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan

Jae-Seung Paick, MD, PhD

Department of Urology, College of Medicine, Seoul National University, Seoul, Korea

David Ralph, BSc, MS, FRCS

Institute of Urology, University College London Hospital, London, UK

Paul de Souza, MD, PhD

Department of Medical Oncology, Liverpool Hospital, Liverpool, NSW, Australia

Jun-Kyu Suh, MD, PhD

Department of Urology, Inha University Hospital, Incheon, Korea

Run Wang, MD, FACS

Department of Urology, University of Texas Medical School, Houston, TX, USA